Background: A number of authors have proposed retrograde arterial embolism as the responsible mechanism for filler-induced blindness. However, no previous human study has substantiated this proposed mechanism. Objectives: The aim of this study was to investigate the pathophysiology of filler-induced blindness using a fresh cadaver perfusion technique. Methods: A fresh cadaver head perfusion model that simulates both physiologic blood pressure and flow rate of the carotid artery, ophthalmic artery, and supratrochlear artery was used. The common carotid artery was cannulated and the internal jugular vein exposed for open venous drainage. A plasma-based perfusate was circulated through the cadaver head, which was connected to a perfusion system consisting of a roller pump, preload reservoir, and pressure monitor. The hyaluronic acid filler mixed with methylene blue was injected into the cannulated superficial branch of the supratrochlear artery. Cadaver dissection, angiographic study, and histology were used to investigate filler-induced blindness. Results: Cannulation of the superficial branch of the supratrochlear artery was successful in all six cadavers. Emboli to the ophthalmic artery was successfully demonstrated in the three out of 6 fresh cadaver heads. The C-arm angiogram documented a cut-off sign in the ophthalmic artery due to hyaluronic acid filler emboli. An average intravascular volume of the intraorbital part of the supratrochlear artery was 50.0 µL. The average depth of location of the superficial branch of the supratrochlear artery from the epidermal surface was 1.5 mm. Conclusions: Our cadaveric study demonstrated that retrograde hyaluronic acid filler emboli to the ophthalmic artery could be produced by the cannulation of the supratrochlear artery. The superficial location of the supratrochlear artery, the rich vasculature surrounding it, and the variability in the anatomy make this possible.
a fresh cadaveric head perfusion model that simulates both physiologic blood pressure and flow rates in the carotid artery, ophthalmic artery, supratrochlear artery, and supraorbital artery and investigate the proposed mechanism of filler-induced blindness ( Figure 1 ).
Finally, the volume and injection pressure needed to create a filler embolus by injecting hyaluronic acid in the cannulated supratrochlear and supraorbital arteries using this fresh cadaveric head perfusion model is described.
A B C Figure 1 . Perfusion system consisting of (A) preload reservoir, (B) roller pump, and pressure monitor is connected to (C) the fresh cadaver head perfusion model of a 76-year-old female that simulates both physiologic blood pressure and flow rate of the carotid artery, ophthalmic artery, supratrochlear artery, and supraorbital artery.
METHODS
Fresh cadaveric dissections were performed at the Cleveland Clinic Simulation & Advanced Skills Center-Surgical Skills Laboratory. Cadavers were obtained in accordance with the Declaration of Helsinki. This study was exempt from institutional review board approval. Six fresh cadaveric heads with no previous history of pathology of the head and neck regions were used for injection studies, and 1 cadaver head was used for histology. The study was carried out from January 2017 to December 2017. For preparation of the cadaveric head perfusion model, the common carotid artery was cannulated, and the internal jugular vein was exposed for open venous drainage. A Jelco® Cathlon ® I.V. Catheter, Clear, 14G × 2.0" was inserted into the common carotid and tied to the vessel wall. To remove the clots from the vessels, 2-meter tubing was connected to the faucet to infuse water, and the arterial and venous systems were pressurized and depressurized for 30-second intervals. After conditioning of the cadaver head, a perfusion system consisting of a roller pump, preload reservoir (Terumo Cardiovascular Systems Corp, Ashland, MA, USA), and pressure monitor (jewel-movement sphygmomanometer, Tycos, Arden, NC, USA) was connected to the catheter (Figure 1 ). The pressure monitor was connected to the Luer-lock connectors. Then, 5 liters of plasma-based perfusate, which is a mixture of Flexbumin (human albumin 25%, Baxter, Westlake Village, CA, USA), swine blood, pigmented dye, saline, and sodium heparin, were circulated through the cadaver head with open venous drainage. The flow rate of perfusion pump was controlled between 0.4 and 1.0 l/min to achieve systolic pressure less than 120 mmHg.
With the cadaver placed in supine position, a SonoSite Edge II (Sonosite, Bothell, Washington, USA) L25x transducer was applied gently to the closed upper eyelid without pressure with coupling gel. Blood flow through the ophthalmic artery was confirmed by color Doppler imaging using the method previously described by Greenfield et al. 10 Additionally, the sonographic investigation was performed in the orbits of the perfused cadaver to detect supratrochlear arteries pulsating in both orbits and forehead.
The supraorbital region was subcutaneously dissected followed by cannulation of the superficial branch of the supratrochlear artery using a 27-gauge × 1", 25 mm, blunt-tipped cannula (Figure 2 ). 11,12 0.29 mL of hyaluronic acid injectable gel (Juvéderm Ultra, Allergan, Inc, Irvine, CA, USA) was thoroughly mixed with 0.01 mL of methylene blue and placed in a 1-mL syringe. The HA filler was injected against the antegrade flow of the perfusate in the supratrochlear artery. Injection pressure was measured with the disposable blood pressure transducers connected to the pressure monitor. As a manually driven syringe may result in the fluctuation of the injection pressure due to the kinesthetic and postural instability of the fingers pushing the plunger, we documented the pressure as a range. Filler injection was continued until there was no flow in the ophthalmic artery detected by color Doppler imaging. The volume of the injected filler was then measured.
A C-arm (Siremobil Iso-C 3D; Siemens Medical Solutions, Erlangen, Germany) was introduced, and angiography of the ophthalmic artery was performed via the internal carotid artery to verify the emboli to the ophthalmic artery. The distribution of the embolus in the orbital vessels was studied using micro-catheter (Echelon 10, EV3 Endovascular Inc., Irvine, CA) injection of a contrast agent Figure 2 . The carotid artery was cannulated for a 64-yearold male cadaver, and a roller pump was run intermittently to help dissect the supratrochlear artery. The pulsatile flow enabled easy identification of this small superficial vessel. The superficial branch of the supratrochlear artery was successfully cannulated in all 7 cadavers. HA filler was then injected into the supratrochlear artery (dashed arrow) using a 27 G blunt-tipped cannula.
(Omnipaque 300 mg/mL, GE Healthcare, Princeton, NJ, USA) as described by Kim et al and Wei et al. 13, 14 The perfusion circuit was disconnected, and osteotomies were made to remove the orbital part of the frontal bone and orbital roof allowing visualization of the orbital structures. Frontal lobectomy was performed, and the bony walls of the optic canal were removed with a high-speed drill to observe the branching pattern of the orbital vessels and the distribution of the filler emboli stained with methylene blue. Using a microcaliper, precise measurement was made of the distance from the midline to the point where the supratrochlear artery crosses the supraorbital rim, the depth of the superficial branch of the supratrochlear artery from epidermal surface, the length of the supratrochlear artery from the point where it crosses the supraorbital rim to the branching point of the ophthalmic artery, and the diameter of the supratrochlear artery at the point where it crossed the superior orbital rim. Statistical analysis included mean and standard deviations using Stata (College Station, TX, software).
A histologic study was performed to microscopically locate the depth of the superficial branch of the supratrochlear artery and calculate the vessel diameter, thus confirming earlier gross measurements. A 20 × 10 mm rectangle with its longer sides in the horizontal direction was drawn on the skin surface approximately 20 mm above the superior margin of the right or left eyebrow along the midsagittal line. A 20 × 10 mm block of cadaveric tissue, which included the superficial branch of the supratrochlear artery, was then obtained. The block was then embedded in paraffin and cut into 6 μm sections in the horizontal plane. The sections were stained with hematoxylin and eosin (H&E). Images were captured using a light microscope (model BX50; Olympus Corp, Tokyo, Japan) and an image analyzer (Image Pro Plus, version 5; Media Cybernetics, Bethesda, Maryland).
RESULTS
Cannulation of the superficial branch of the supratrochlear artery was successful in all 6 cadavers. There were 3 male cadavers and 3 female cadavers. The mean age was 71.7 years (range, 65-80). After the retrograde injection of HA filler, cadaver dissection verified the HA/methylene blue emboli in the ophthalmic artery in 3 of 6 cadaver heads ( Figures 3, 4B, and 5B).
The supratrochlear artery was found to branch off proximal to the corrugator supercilii muscle to give rise to the superficial branch and the deep periosteal branch ( Figure 5B ). 11, 12 The deep branch of the supratrochlear artery then penetrated the corrugator supercilii muscle before it reached the pericranium. The superficial branch initially coursed cephalad between the corrugator and orbicularis oculi muscles and then ran superficial to A B the frontalis muscle to travel in the subcutaneous plane from 15 mm to 25 mm above the orbital rim ( Figure 6 ). Anastomoses of the supratrochlear artery, the dorsal nasal artery, with the angular artery were below the eyebrow along the side of the radix ( Figure 5B ). The average distance from the midline to the point where the supratrochlear artery crosses the supraorbital rim was 18.1 mm (SD, 2.1; range, 15.2-21.3 mm) ( Table 1 ). The average depth of the superficial branch of the supratrochlear artery from the epidermal surface was 1.5 mm (SD, 0.2; range, 1.3-1.8 mm) ( Figure 6 ). The average diameter of the supratrochlear artery at the point where it crosses the superior orbital rim was 1.13 mm (SD, 0.34; range, 0.84-1.56 mm) ( Figure 5A ). The diameter of the supratrochlear artery in those cadavers that were successfully embolized was 1.42 mm (range, 1.23-1.56 mm), whereas the average diameter was 0.84 mm (range, 0.84-0.93 mm), significantly smaller for the unsuccessful ones. The average injection pressure needed to embolize the ophthalmic artery was 166.7 mmHg (range, 160-180 mmHg).
The average length of the supratrochlear artery from the point where it crosses the supraorbital rim to the branching point of the ophthalmic artery was 51.1 mm (SD, 11.25; range, 36.6-67.4 mm) ( Figure 5A ). The calculated intraorbital volume of the supratrochlear artery after branching off from the ophthalmic artery ranged from 30.1 µL to 80.2 µL. The average vessel volume was 50.0 µL.
The filler/methylene blue emboli were noted not only in the orbital arteries but also in the dorsal nasal artery and anastomotic channels between the supratrochlear artery and the supraorbital artery ( Figure 5B ).
Histologic Studies
Microscopic observations of the forehead skin specimens from the seventh cadaver revealed the following findings. Depth of the superficial branch of the supratrochlear artery was 1.628 mm from the epidermal surface ( Figure 7 ). The circumference of the artery was 4.222 mm. Considering it as a cylindrical structure, calculated luminal diameter of the artery was 1.34 mm.
DISCUSSION

Experimental Study Design
Human cadaver circulation models have been used to help in the design of a variety of neurovascular and endovascular devices because they so closely simulate the clinical situation. 15, 16 We have borrowed from those designs in order to investigate the pathophysiology of filler-induced blindness.
In a review of the literature detailing filler-induced visual changes, the glabella was the most common injection site implicated accounting for 38 of 98 (38.8%) cases in the largest reported study. 4 Therefore, the supratrochlear artery was the injection site chosen in this study.
Anatomic Findings of the Branches of the Ophthalmic Artery
The supratrochlear artery, the terminal branch of the ophthalmic artery, has been described as most commonly piercing the orbital septum to enter the forehead and scalp. But it may also arise anterior to the septum anastomosing with the surrounding arteries ( Figure 5B ). 17, 18 In all 7 of our cadavers, the supratrochlear artery pierced through the orbital septum and formed a network of anastomoses, consistent with previous reports. 19 The vascular relationship between the angular artery, the supratrochlear artery, and dorsal nasal artery, however, was not always consistent with previous reports. 20 The dorsal nasal artery pierced the orbital septum above the medial palpebral ligament to run on top of the nose ( Figure 5B) . It represents the other terminal branch of the ophthalmic artery, and it establishes an important anastomosis with the angular branch of the facial artery. 17, 18 Anatomic Findings of the Supratrochlear Artery
Both our study and the work of others highlight why the supratrochlear vessels are so frequently implicated in filler-induced blindness. We found that the supratrochlear artery is surprisingly superficial, lying 1.5 mm (SD, 0.2; range, 1.3-1.8 mm) deep to the epidermal surface. This makes inadvertent cannulation or injection very possible. This finding was contrary to a previous report suggesting superficial injection in the glabellar region is relatively safe. 21 The distance of the supratrochlear artery from the midline has been studied by others. 19, 23 However, we found the location of the supratrochlear artery far more lateral than previous reports. Our study found the vessel to be 18.1 ± 2.1 mm (range, 15.2-21.3 mm) from the midline, whereas Tansatit et al reported an average distance of 11.3 ± 1.9 mm (range, 9-19 mm) and Schwenn et al a distance of 16.4 ± 2.2 mm (range, 14-21 mm) from the midline (Table 1 ). In addition, we found the vascular relationships among the angular artery, the supratrochlear artery, and dorsal nasal artery form both a very rich and inconsistent anatomic relationship. This rich vascularity and variable anatomy enhance the likelihood of needle induced misadventure.
The outer diameter of the supratrochlear artery was measured both grossly and histologically. Gross measurement of the supratrochlear artery demonstrated an outer diameter of 1.13 ± 0.34 mm (range, 0.84-1.56 mm). Microscopic finding demonstrated a calculated luminal diameter of 1.34 mm, which is larger than an 18 gauge needle (1.27 mm). 24 Others have found the diameter to be somewhat smaller. 23, 25, 26 In any case, as the diameter of the vessel may well be larger than the injection needle used, cannulation or penetration of the lumen is readily possible. Those cadavers that were unsuccessfully embolized had on average a smaller diameter of the supratrochlear artery.
In order to estimate the volume of filler needed to create a filler embolism, the intravascular volume of the supratrochlear artery and ophthalmic artery from the glabella to the orbital apex was calculated as 50 µL (SD, 21.1; range, 30.1-80.2 µL). This is similar to the findings of Schwenn et al and Khan et al. 23, 25 In any case, the volume needed to induce an embolus in both models is exceedingly small.
Injection Pressure for Embolism of Filler
The average injection pressure that was needed to embolize the ophthalmic artery was 166.7 mmHg ( Table 2) . Monitoring of the injection pressure showed that it is easy for the injector to exert the pressure well above 200 mmHg within 2 to 3 seconds. Also, it was not easy to keep the injection pressure below 80 mmHg, as the injector needs a certain amount of pressure on the syringe to push the material through a small needle. Whether the injector needs to overcome the diastolic blood pressure or systolic blood pressure to create an embolus in the ophthalmic artery is controversial. Paul et al claimed that corticosteroid embolization can occur when injection pressure exceeds the diastolic pressure of the ophthalmic artery. 27 On the other hand, Li et al suggested that injection force needs to overcome the systolic arterial pressure in order to push the injected droplets of filler proximally along the ophthalmic artery. 21 In our study, the injection pressure above the systolic arterial pressure was needed to transfer the filler into the ophthalmic artery. This reaffirms the clinical recommendation that excessive syringe pressure should be avoided during the filler procedure. The pressure during the injection is likely to be dispersed to multiple vessels rather than transmitted to one artery. This is consistent with the present dissection findings, which showed that the filler was not only injected into the orbital vessels but also into the dorsal nasal artery and anastomotic channels between the supratrochlear artery and the supraorbital artery (Figures 4 and 5) . This is consistent with clinical findings of skin necrosis occurring in the radix and nasojugal groove after filler injection to the glabella. 13 Although our experiment did not measure the flow rate of the filler through the cannula, this is also another important factor that can affect the retrograde embolism. A slow injection rate affects the viscosity of HA filler, which demonstrates the typical behavior of non-Newtonian liquids. 28 With increasing shear rate of HA filler during the injection, viscosity drops. 29 In contrast, the viscosity of the HA filler increases at low flow rates. As a result, the resistance of the filler is greater during the initiation of the injection than when the flow is established. Therefore, the injector needs to apply a greater amount of pressure to initiate flow. 30 This higher initial pressure is directly transmitted during the injection. Therefore a slow injection with a high initial injection pressure combined with a sufficient volume of HA filler can increase the possibility of retrograde embolism. 
Angiographic Findings in Retrograde Filler Injection
Angiography has been used to study various orbital vasculature. Kim et al have used cerebral angiograms to localize filler-induced ophthalmic embolic obstruction sites and characterize the pattern of distal angiographic runoff. 13 Wei et al described use of the C-arm angiography as a reasonable and practical diagnostic tool to identify vascular lesions intraoperatively. 14 We also used the C-arm for our study. It should, however, be noticed that the C-arm presents with relatively reduced image resolution and restricted imaging angle compared to a standard biplane digital subtraction angiography. 14 A high-resolution angiogram would likely have shown a more precise level of obstruction. 
Future Directions for Further Filler Research
The results of the study can well be extended. Possible avenues for further research include evaluation of various hyaluronidase dosage and treatment intervals on intravascular HA dissolution, the effect of previous surgery (ie, vascular anatomy alteration) on filler embolus propagation, and the size of vessels on embolus propagation.
Limitations of the Study
The numbers of the cadavers included in the study were small, and the age group did not represent the typical filler patients. Although our model simulates both physiologic blood pressure and flow rate, it falls short of true physiology. For example, it lacks a vasoconstriction or closure of the collateral circulation, which can occur under external stimuli in physiologic conditions. 31 Also, the cannulation of the artery was done under direct vision, which affects the success rate of the intravascular injection of the HA filler. The mean age of the 7 cadavers included in this study was 71.7 years (range, 65-80). According to the cosmetic surgery national data bank statistics, in 2016, people aged 35 to 60 accounted for 37.4% of hyaluronic acid filler treatment followed by age group 51 to 64 (34.4%). 32 People the age 65 and older accounted for 13.3% of the HA injection. Therefore, the mean age of the cadavers was older than the typical filler patients. Finally, this study sends a cautionary note to the clinician. The practicing plastic surgeon should not be reassured by the rarity of this event. This study suggests that because of the superficial location of the supratrochlear artery, the rich vascularity surrounding it, and the variability in this anatomy the possibility of filler-induced blindness is real. And while this is a minor office procedure, the clinician should be prepared for this major event.
CONCLUSIONS
In this study, we demonstrate that retrograde filler embolus to the ophthalmic artery can be reproduced by cannulation of the supratrochlear artery. This may be the pathophysiology, which results in filler related visual changes. Further, because the supratrochlear artery is so superficial, ophthalmic artery emboli are possible even with superficial filler injection. The superficial location of the supratrochlear artery, the rich vasculature surrounding it, and the variability of the anatomy make the possibility of filler-induced blindness real.
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